AFYREN NEOXY Receives €3.4 Million Milestone Payment as Part of the AFTER-BIOCHEM Project
21 Marzo 2024 - 7:45AM
Business Wire
- AFYREN NEOXY receives third tranche of EU funding to the
AFTER-BIOCHEM consortium
- Consortium led by AFYREN NEOXY and gathering 12 leading
industrial partners from 5 European countries
- AFTER-BIOCHEM project will continue with the support of CBE
JU
Regulatory News:
AFYREN (Paris:ALAFY), a greentech company that offers
manufacturers natural, low-carbon products created with technology
based on natural micro-organisms, announced today that AFYREN NEOXY
received a €3.4 million payment in recognition of milestones the
plant reached.
The payment, recognised in the 2023 accounts of AFYREN NEOXY, is
the third instalment of a €20 million grant from the Circular
Bio-based Europe Joint Undertaking (CBE JU1), a public-private
partnership of the European Union of the Framework Programme for
Research and Innovation. This project known as AFTER-BIOCHEM, was
granted in 2020 to a consortium of 12 partners led by AFYREN NEOXY.
This consortium is working toward a common goal: creating
sustainable value chains from renewable and non-food raw material
and making bio-based chemical building blocks available at scale
for industry. In addition to the production of acids, the
project’s scope includes work on the downstream market, where the
acids are used as building blocks for other products in markets
including food and feed; flavors and fragrances; lubricants and
technical fluids. The third grant instalment was approved after an
independent panel of experts determined that the AFTER-BIOCHEM
project had met a set of achievements.
The 12
European project partners
- 4 SMEs: AFYREN NEOXY, PNO, SPHERA, TERRIAL
- 7 large industries: CELANESE, SÜDZUCKER, FIRMENICH,
SUEZ, KEMIN,TECHNIP ENERGIES, FIABILA
- 1 Cluster: BIOECONOMY FOR CHANGE
The AFTER-BIOCHEM project will continue, with the support of CBE
JU. A particular focus will be put on plant performance during
production phase, including life cycle analysis and product
performance analysis with end-user partners. Further developments
such as plant replication and new products projects will also be
assessed.
With the latest payment, total support from CBE JU to
AFTER-BIOCHEM reaches €16 million over the past four years, of
which 90% was directly invested in AFYREN-NEOXY. These funds have
contributed to all development phases of the plant: construction,
commissioning and ramp-up. The factory represents an initial total
CAPEX of around €62 million. The French state investment bank BPI
has a 49% stake in AFYREN NEOXY.
AFYREN NEOXY is expected to start continuous production of its
biobased acids in 2024 and reach financial breakeven2 in 2025.
Nicolas Sordet, CEO of AFYREN, commented: "This latest
instalment of funds and the continuation of the project, underscore
the progress made by our partners and us toward our differentiated
sustainable solutions. We are grateful for the CBE JU's excellent
work turning European vision into reality, advancing the bio-based
sector by helping rallying stakeholders around a common goal. As we
prepare for a very active 2024, I'll take this opportunity to thank
all our investors and supporters, public and private."
About AFTER-BIOCHEM AFTER-BIOCHEM is a unique opportunity
to turn agricultural processing co-products into new product
streams. The project core technology is based on 10 years of
R&D at AFYREN. The technology can turn biomass into high
added-value and natural products using its all-in-one cutting edge
fermentation process based on natural micro-organisms (100%
GMO-free process and products). The project will also implement a
"zero waste" strategy based on an optimised production process; all
the fermentation outputs are valorised into valuable products:
seven organic acids and one mineral co-product that can be used
respectively as ingredients and fertiliser. The bio-based and
natural compounds will have applications in various markets such as
food and feed, fragrances and flavors, personal care,
pharmaceuticals, and industrial chemicals.
About AFYREN AFYREN is a French greentech company
launched in 2012 to meet the challenge of decarbonizing industrial
ingredients. Its innovative, unique and proprietary fermentation
technology valorizes local biomass from non-food agricultural
co-products, replacing petro-sourced compounds used in many
industrial product formulations. AFYREN's 100% biobased, low-carbon
and sustainable solutions can meet decarbonization challenges in a
wide variety of strategic sectors: human and animal nutrition,
flavors and fragrances, life sciences and materials, and lubricants
and technical fluids. AFYREN's plug-and-play, circular technology
combines sustainability and competitiveness, with no need for
manufacturers to change their processes. The Group's first French
plant, AFYREN NEOXY, a joint venture with Bpifrance's SPI fund, is
located in the Grand-Est region of France, in Saint Avold, serving
mainly the European market. AFYREN is also pursuing a project in
Thailand with a world leader in the sugar industry, and is
developing its presence in the Americas, following up on
distribution agreements it has already signed.
At the end of 2023, AFYREN employed about 120 people in Lyon,
Clermont-Ferrand and Carling Saint-Avold. The company invests 20%
of its annual budget in R&D to further develop its sustainable
solutions.
AFYREN has been listed on the Euronext Growth® exchange in Paris
since 2021 (ISIN code: FR0014005AC9, mnemonic: ALAFY).
Find out more: afyren.com
_____________________________ 1 Previously known as BBI JU
(Bio-based Industries Joint Undertaking) 2 Positive production
EBITDA
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240320493044/en/
AFYREN Director for ESG, Communications and Public
Affairs Caroline Petigny caroline.petigny@afyren.com
Investor Relations Mark Reinhard
investisseurs@afyren.com
NewCap Investor Relations Théo Martin / Mathilde
Bohin Tel: 01 44 71 94 94 afyren@newcap.eu
NewCap Media Relations Nicolas Merigeau / Gaëlle
Fromaigeat Tel: 01 44 71 94 98 afyren@newcap.eu
International Media relations Bogert-Magnier
Communications James Connell +33 6 2152 1755
jim@bogert-magnier.com
Grafico Azioni Afyren (EU:ALAFY)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Afyren (EU:ALAFY)
Storico
Da Nov 2023 a Nov 2024